🇺🇸 FDA
Drug

cisplatin

Brand: CISPLATIN

approved

Quick answer

cisplatin (CISPLATIN), is a pharmaceutical active ingredient, associated with TEVA PHARMACEUTICAL INDUSTRIES LTD, with approved status in the US.

Key facts

INN
cisplatin
Brand
CISPLATIN
Route
INJECTION
Formulation
INJECTABLE
Originator
TEVA PHARMACEUTICAL INDUSTRIES LTD

Related patents

patent

US 11013740

Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induce

Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10272084

Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induce

Expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 8703756

Synthetic procedure and cancer treatment with cisplatin derivatives

Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 7700134

Prevention of cisplatin induced deafness

Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is cisplatin?

cisplatin (CISPLATIN), is a pharmaceutical active ingredient, associated with TEVA PHARMACEUTICAL INDUSTRIES LTD, with approved status in the US.

What is the brand name for cisplatin?

CISPLATIN is a marketed brand name for cisplatin. Check FDA Drugs@FDA for the current US label holder.